DATASHEET
Host:
Rabbit
Target Protein:
Synaptotagmin
Specificity:
This antibody will cross-react with Synaptotagmin 2 and
Immunogen Range:
165-260/422
Clonality:
Polyclonal
Isotype:
IgG
Entrez Gene:
6857
Swiss Prot:
P21579
Source:
KLH conjugated synthetic peptide derived from human Synaptotagmin 1
Purification:
Purified by Protein A.
Storage Buffer:
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage:
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Background:
May have a regulatory role in the membrane interactions during trafficking of synaptic vesicles at the active zone of the synapse. It binds acidic phospholipids with a specificity that requires the presence of both an acidic head group and a diacyl backbone. A Ca(2+)-dependent interaction between synaptotagmin and putative receptors for activated protein kinase C has also been reported. It can bind to at least three additional proteins in a Ca(2+)-independent manner; these are neurexins, syntaxin and AP2.
PRODUCT SPECIFIC PUBLICATIONS
- Wang J et al. EphrinB/EphB signaling contributes to the synaptic plasticity of chronic migraine through NR2B phosphorylation. Neuroscience. 2020 Jan 21;428:178-191. Read more>>
- Wang, Yunfeng. et al. Repeated oxytocin prevents central sensitization by regulating synaptic plasticity via oxytocin receptor in a chronic migraine mouse model. J Headache Pain. 2021 Dec;22(1):1-16Read more>>
VALIDATION IMAGES
L1 rat heart, L2 rat brain lysates probed (bs-4172R) at 1:200 in 4˚C. Followed by conjugation to secondary antibody (bs-0295G-HRP) at 1:3000 90min in RT. Predicted and observed band size: 46kDa.\n
Formalin-fixed and paraffin embedded rat brain tissue labeled with Anti-Synaptotagmin 1/SYT1 Polyclonal Antibody, Unconjugated (bs-4172R) at 1:200 followed by conjugation to the secondary antibody, (SP-0023), and DAB staining
Lane 1: Human HepG2 cell lysates; Lane 2: Human A673 cell lysates; Lane 3: Human HeLa cell lysates probed with Synaptotagmin 1 Polyclonal Antibody, Unconjugated (bs-4172R) at 1:500 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.